Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Clofarabine/Busulfan x 4
DRUG
2 trials
Sponsors
University of Michigan Rogel Cancer Center
Conditions
Acute Myeloblastic Leukemia
Hodgkin Lymphoma
Leukemia
Multiple Myeloma
Myelodysplastic Syndrome
Non-Hodgkin Lymphoma
Phase 1
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
Completed
NCT00556452
University of Michigan Rogel Cancer Center
Hodgkin Lymphoma, Leukemia, Multiple Myeloma +2
Start: 2007-10-31
End: 2012-09-30
Updated: 2017-12-05
Phase 2
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Completed
NCT01457885
University of Michigan Rogel Cancer Center
Acute Myeloblastic Leukemia
Start: 2011-11-30
End: 2016-06-14
Updated: 2017-06-02
Related Papers
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.
2011-08-12
44 citations